Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element
about
The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylationA negative elongation factor for human RNA polymerase II inhibits the anti-arrest transcript-cleavage factor TFIIS.The Drosophila 7SK snRNP and the essential role of dHEXIM in development7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcriptionDevelopmental regulators containing the I-mfa domain interact with T cyclins and Tat and modulate transcriptionMolecular characterization of Drosophila NELFA new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongationTranscriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cureCoupling pre-mRNA processing to transcription on the RNA factory assembly lineCyclin Box Structure of the P-TEFb Subunit Cyclin T1 Derived from a Fusion Complex with EIAV TatCrystal structure of the human transcription elongation factor DSIF hSpt4 subunit in complex with the hSpt5 dimerization interfaceCracking the control of RNA polymerase II elongation by 7SK snRNP and P-TEFbInhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNAPhosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytesUp-regulation of P-TEFb by the MEK1-extracellular signal-regulated kinase signaling pathway contributes to stimulated transcription elongation of immediate early genes in neuroendocrine cellsThe positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylationRepression of RNA polymerase II elongation in vivo is critically dependent on the C-terminus of Spt5.Regulation of RNA polymerase II termination by phosphorylation of Gdown1.Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat.Phosphorylation of serine 177 of the small hepatitis delta antigen regulates viral antigenomic RNA replication by interacting with the processive RNA polymerase II.Human negative elongation factor activates transcription and regulates alternative transcription initiation.Mechanisms of HIV Transcriptional Regulation by Drugs of Abuse.Mechanism and factors that control HIV-1 transcription and latency activationThe Human Immunodeficiency Virus 1 ASP RNA promotes viral latency by recruiting the Polycomb Repressor Complex 2 and promoting nucleosome assemblyUbiquitylation of Cdk9 by Skp2 facilitates optimal Tat transactivation.Interactions between DSIF (DRB sensitivity inducing factor), NELF (negative elongation factor), and the Drosophila RNA polymerase II transcription elongation complexTranscriptional and posttranscriptional regulation of HIV-1 gene expressionBET bromodomain inhibition as a novel strategy for reactivation of HIV-1Control of transcriptional elongation.RNA polymerase II transcription elongation and Pol II CTD Ser2 phosphorylation: A tail of two kinases.RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus.Enhancer RNA facilitates NELF release from immediate early genesThe RNA polymerase II CTD coordinates transcription and RNA processing.Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein.CDK9 and H2B monoubiquitination: a well-choreographed dance.The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit.Pathogenesis and treatment of HIV infection: the cellular, the immune system and the neuroendocrine systems perspective.Properties of RNA polymerase II elongation complexes before and after the P-TEFb-mediated transition into productive elongation.Short chain fatty acids potently induce latent HIV-1 in T-cells by activating P-TEFb and multiple histone modifications.
P2860
Q24323313-8796F91A-044C-4786-AF9F-7A98DFD5243FQ24536049-6E9A034C-3430-40FF-AD26-BA0812624E43Q24597477-BD6F8B70-CAC8-46CE-B85D-8E607E18B8DBQ24634280-088D1F35-11BE-4B86-92C3-CCEDD44275FBQ24684924-D8C724BE-83C1-48D6-90E0-9F29700F1BA1Q24798796-70C4D22E-4F33-40D0-8E9A-0D58FC45DF24Q24804709-A6ABE37F-7A0B-43C8-B4C2-EE428A1635C3Q26999858-12034F8F-F5BD-40AF-8020-5561665E603EQ27024720-89DE537D-4933-4B46-9ACF-5238C79D832EQ27645094-8D6EBFD9-CA78-4936-84B5-F15F5E5559EBQ27657998-FF90B0AF-AC36-4FFB-8AF9-08FF112DB5EFQ28276848-3A8FE720-E5E5-4B63-8321-A78A6CA7030CQ28478188-AA128F3D-36B1-4DBF-B791-5F63EC8DBD9FQ28487524-61C0A238-3C5C-4E54-AB67-4B1BBAE6E45CQ28572356-66F12C7D-555D-481F-8F41-12DB650AAD74Q28595060-EF161A20-D7FC-4812-BC1F-5C4814C54100Q30429511-6472F689-81D2-4010-B755-06D1C8B7AED6Q33501748-FD1C0D64-1185-4E76-83AD-3372DE3D4865Q33556203-2C772FA4-E5AF-4C48-918E-FBE0FBB2226CQ33602605-15E9F9AC-23E2-4A08-B7C7-EF92FE59B1EBQ33614472-3359C12F-0420-45B3-8837-D30D6313E764Q33673701-37FAEA39-A699-4701-A55D-2DD9DBF4FB2FQ33815611-DA6E5545-096D-4FDF-AE8F-9ACA501EDF09Q33826920-28D9EC79-922A-4077-8AB3-826603101F22Q33893725-12BD50F3-9AC8-463F-B974-45CB1F6472ECQ33930482-0019AB18-546C-48E5-BB80-5AF063E286A4Q33953149-044D9ECA-D747-4CAC-BB8D-4A2FBC2CA2C8Q34030804-074E5561-5EE3-4FD8-B41A-6046C46B8DC8Q34032827-A6E3C6DC-1AA2-452C-A51E-1F290EB0BEE9Q34038245-695DA26B-DBF6-4000-8967-B934148E5A4EQ34046663-B0C5DFCC-3D2A-47FA-8AD7-F80A86BFCD03Q34064221-30D9A19A-8B63-48D6-9BC0-6402B0E78673Q34292008-AFD8D52B-29B0-4AB1-9353-212894D42337Q34303212-080DCDF4-7DE8-4AF4-BF1B-8602AD6957E7Q34353375-E6964205-5506-44D1-A37C-41992B9A824DQ34372370-0C7FD0C4-59CD-4F9A-886E-5BC6CA4A5104Q34544409-D60D39B5-8A2A-4380-94D0-6FCD1A7B9EA8Q34650866-D4997706-E61C-4964-871F-4D6010DA3779Q34654219-F1EABABA-B9C5-40D3-81B9-AFE6E378A513Q34656952-8B4FA6BE-C662-46A2-8F65-0D5E4BB9CCF6
P2860
Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element
description
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im Januar 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/01/01)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/01/01)
@nl
наукова стаття, опублікована в січні 2004
@uk
مقالة علمية (نشرت عام 2004)
@ar
name
Dynamics of human immunodefici ...... ansactivation response element
@ast
Dynamics of human immunodefici ...... ansactivation response element
@en
Dynamics of human immunodefici ...... ansactivation response element
@nl
type
label
Dynamics of human immunodefici ...... ansactivation response element
@ast
Dynamics of human immunodefici ...... ansactivation response element
@en
Dynamics of human immunodefici ...... ansactivation response element
@nl
prefLabel
Dynamics of human immunodefici ...... ansactivation response element
@ast
Dynamics of human immunodefici ...... ansactivation response element
@en
Dynamics of human immunodefici ...... ansactivation response element
@nl
P2093
P2860
P3181
P1476
Dynamics of human immunodefici ...... ansactivation response element
@en
P2093
B. Matija Peterlin
Koh Fujinaga
Takeshi Kurosu
Yehong Huang
P2860
P304
P3181
P356
10.1128/MCB.24.2.787-795.2004
P407
P577
2004-01-01T00:00:00Z